Basilea Pharmaceutica (0QNA) Ownership - Who Owns Basilea Pharmaceutica?
Basilea Pharmaceutica (0QNA) Ownership Overview
- 3.60% Mutual Funds
- 0.11% Other Institutional Investors
- 11.07% ETFs
- 85.22% Public Companies and Individual Investors
The ownership structure of Basilea Pharmaceutica (GB:0QNA) stock is a mix of institutional, retail, and individual investors. Approximately 14.78% of the company’s stock is owned by Institutional Investors, and 85.22% is owned by Public Companies and Individual Investors.
The ownership structure of Basilea Pharmaceutica (GB:0QNA) stock is a mix of institutional, retail, and individual investors. Approximately 14.78% of the company’s stock is owned by Institutional Investors, and 85.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 392,571 | Institution | 2.92% | 33,745,011 |
| Xtrackers | 332,474 | Institution | 2.47% | 28,579,133 |
| Avantis | 327,566 | Institution | 2.44% | 28,157,246 |
| Ishares | 259,171 | Institution | 1.93% | 22,278,080 |
| Vanguard Star Funds | 177,071 | Institution | 1.32% | 15,220,846 |
| Vanguard Tax-managed Funds | 118,139 | Institution | 0.88% | 10,155,110 |
| Vanguard International Equity Index Funds | 88,116 | Institution | 0.66% | 7,574,363 |
| Dimensional | 62,033 | Institution | 0.46% | 5,332,295 |
| Ubs | 57,204 | Institution | 0.43% | 4,917,199 |
| Dfa Investment Dimensions Group Inc | 48,933 | Institution | 0.36% | 4,206,232 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 177,071 | Institution | 1.32% | 15,220,846 |
| Vanguard Tax-managed Funds | 118,139 | Institution | 0.88% | 10,155,110 |
| Vanguard International Equity Index Funds | 88,116 | Institution | 0.66% | 7,574,363 |
| Dfa Investment Dimensions Group Inc | 48,933 | Institution | 0.36% | 4,206,232 |
| Old Westbury Funds Inc | 21,727 | Institution | 0.16% | 1,867,631 |
| American Century Etf Trust | 11,529 | Institution | 0.09% | 991,021 |
| Fidelity Salem Street Trust | 8,333 | Institution | 0.06% | 716,296 |
| Fidelity Concord Street Trust | 3,606 | Institution | 0.03% | 309,968 |
| State Street Institutional Investment Trust | 3,312 | Institution | 0.02% | 284,696 |
| Voya Mutual Funds | 2,155 | Institution | 0.02% | 185,242 |
FAQ
What percentage of Basilea Pharmaceutica (GB:0QNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.78% of Basilea Pharmaceutica (GB:0QNA) stock is held by institutional investors: 3.60% by mutual funds, 11.07% by ETFs and 0.11% by other institutional investors.
What percentage of Basilea Pharmaceutica (GB:0QNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.22% of Basilea Pharmaceutica (GB:0QNA) stock is held by public companies and individual investors.
Who owns the most shares of Basilea Pharmaceutica (GB:0QNA)?
Vanguard owns the most shares of Basilea Pharmaceutica (GB:0QNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
